Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;32(6):347-353.
doi: 10.1016/j.clon.2020.04.005. Epub 2020 Apr 24.

Clinical Guidance for the Management of Patients With Urothelial Cancers During the COVID-19 Pandemic - Rapid Review

Affiliations
Free PMC article
Review

Clinical Guidance for the Management of Patients With Urothelial Cancers During the COVID-19 Pandemic - Rapid Review

K Patel et al. Clin Oncol (R Coll Radiol). .
Free PMC article

Abstract

The current COVID-19 pandemic presents a substantial obstacle to cancer patient care. Data from China as well as risk models suppose that cancer patients, particularly those on active, immunosuppressive therapies are at higher risks of severe infection from the illness. In addition, staff illness and restructuring of services to deal with the crisis will inevitably place treatment capacities under significant strain. These guidelines aim to expand on those provided by NHS England regarding cancer care during the coronavirus pandemic by examining the known literature and provide guidance in managing patients with urothelial and rarer urinary tract cancers. In particular, they address the estimated risk and benefits of standard treatments and consider the alternatives in the current situation. As a result, it is recommended that this guidance will help form a framework for shared decision making with patients. Moreover, they do not advise a one-size-fits-all approach but recommend continual assessment of the situation with discussion within and between centres.

Keywords: COVID-19; Chemotherapy; Guidelines; Radiotherapy; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Urothelial cancer.

Similar articles

See all similar articles

Supplementary concepts

Feedback